Carnegie Investment Counsel’s Milestone Scientific MLSS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLSS
SFA
KAS
RCM
DIGI
DSAM
Carnegie Investment Counsel's MLSS Position: Q2 2026 in Review
Carnegie Investment Counsel held its Milestone Scientific (MLSS) position steady in Q2 2026 at 100,175 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #546.
Carnegie Investment Counsel first reported a position in MLSS in Q3 2023 and has held it in 11 quarters since. The position peaked at $166K in Q4 2024. 12 funds tracked by Wall St. Rank hold MLSS as of Q2 2026.
- Carnegie Investment Counsel held 100,175 shares of Milestone Scientific worth $32.2K as of Q2 2026.
- Carnegie Investment Counsel left its Milestone Scientific share count unchanged in Q2 2026.
- Milestone Scientific made up ﹤0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #546 holding.
- Carnegie Investment Counsel first reported a position in Milestone Scientific in Q3 2023 and has held it in 11 quarters since.
- Carnegie Investment Counsel's Milestone Scientific position peaked at $166K in Q4 2024.
- 12 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.